H.C.
Second Sight Medical Products Inc (NASDAQ:EYES) shares are up nearly 6% this morning, following the news that the company has received approval from …
Second Sight Medical Products Inc (NASDAQ:EYES) announced that the Company has received conditional approval from the FDA to begin the Orion™ Cortical Visual Prosthesis …
Second Sight Medical Products Inc (NASDAQ:EYES) announced that the Argus® II Retinal Prosthesis System (Argus II) has been implanted in the first patient …
Second Sight Medical Products Inc (NASDAQ:EYES) announced that the German Institute for the Hospital Remuneration System (InEK) has renewed Status 1 (full approval) …
Second Sight Medical Products Inc (NASDAQ:EYES) announced it filed a registration statement on Form S-1 with the Securities and Exchange Commission or a …
Second Sight Medical Products Inc (NASDAQ:EYES) announced, following a positive recommendation from advisors to the UK Government’s healthcare funding authority for specialized services …
In a research report published Wednesday, H.C.
Second Sight Medical Products Inc (NASDAQ:EYES) announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing …
Second Sight Medical Products Inc (NASDAQ:EYES), the developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, …
